Date: Tuesday 19 Feb 2013
Cancer drug developer Antisoma saw a return to the red at its half-year report statement, reporting a 30,000 pound loss after tax.
| Small caps round-up: Transense Tech, WH Ireland,... | 23-Mar-2012 | ShareCast |
| London close: Footsie back at 5,900 | 25-Mar-2011 | ShareCast |
| London afternoon: Gaming firms in demand | 25-Mar-2011 | ShareCast |
| TechMARK movers: Cryptologic reviews strategy | 25-Mar-2011 | ShareCast |
| TechMARK movers: Ark valued at discount to NAV | 09-Mar-2011 | ShareCast |
| Holding(s) in Company | 02-May-2013 | 15:52 | RNS |
| TR-1 Notification of Major Interest in Shares | 18-Apr-2013 | 15:31 | RNS |
| TR1 Notification of major interest in shares | 11-Apr-2013 | 13:50 | RNS |
| Placing Agreement with Silence Therapeutics plc | 10-Apr-2013 | 13:11 | RNS |
| Placing Agreement with Plant Health Care | 28-Mar-2013 | 10:54 | RNS |
| Bitter pill for Antisoma as drug is failed | 01-Feb-2011 | Daily Mail |
| Antisoma shares plunge after latest cancer drug ... | 01-Feb-2011 | The Independent |
| Need to know: Opec cuts forecast ... Tesco cuts ... | 16-Aug-2008 | Times |
| Antisoma acquires US rival Xanthus | 17-May-2008 | Telegraph |
| Antisoma hits the acquisition trail | 22-Feb-2008 | The Scotsman |
| Tempus:Antisoma | 15-Sep-2009 | Times |
| Questor:Antisoma | 15-Sep-2009 | Telegraph |
| Market report: Thursday latest | 17-Jul-2008 | Daily Mail |
| Alliance & Leicester gets a savaging | 22-Feb-2008 | Guardian |
| LeFrak eyes Minerva's prime London sites | 22-Feb-2008 | Telegraph |
| Currency | UK Pounds |
| Share Price | 1.68p |
| Change Today | 0.025p |
| % Change | 1.52 % |
| 52 Week High | 1.98 |
| 52 Week Low | 1.48 |
| Volume | 0 |
| Shares Issued | 639.36m |
| Market Cap | £10.71m |
| RiskGrade | 157 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
You are here: research